1. Home
  2. ORIC vs THRY Comparison

ORIC vs THRY Comparison

Compare ORIC & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • THRY
  • Stock Information
  • Founded
  • ORIC 2014
  • THRY 2003
  • Country
  • ORIC United States
  • THRY United States
  • Employees
  • ORIC N/A
  • THRY N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • THRY Industrial Machinery/Components
  • Sector
  • ORIC Health Care
  • THRY Industrials
  • Exchange
  • ORIC Nasdaq
  • THRY Nasdaq
  • Market Cap
  • ORIC 735.3M
  • THRY 744.4M
  • IPO Year
  • ORIC 2020
  • THRY 2020
  • Fundamental
  • Price
  • ORIC $7.68
  • THRY $18.15
  • Analyst Decision
  • ORIC Strong Buy
  • THRY Strong Buy
  • Analyst Count
  • ORIC 10
  • THRY 3
  • Target Price
  • ORIC $19.13
  • THRY $24.33
  • AVG Volume (30 Days)
  • ORIC 1.6M
  • THRY 473.8K
  • Earning Date
  • ORIC 02-18-2025
  • THRY 02-27-2025
  • Dividend Yield
  • ORIC N/A
  • THRY N/A
  • EPS Growth
  • ORIC N/A
  • THRY N/A
  • EPS
  • ORIC N/A
  • THRY N/A
  • Revenue
  • ORIC N/A
  • THRY $873,723,000.00
  • Revenue This Year
  • ORIC N/A
  • THRY N/A
  • Revenue Next Year
  • ORIC N/A
  • THRY N/A
  • P/E Ratio
  • ORIC N/A
  • THRY N/A
  • Revenue Growth
  • ORIC N/A
  • THRY N/A
  • 52 Week Low
  • ORIC $6.33
  • THRY $13.06
  • 52 Week High
  • ORIC $16.65
  • THRY $26.42
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 36.65
  • THRY 51.88
  • Support Level
  • ORIC $7.34
  • THRY $19.33
  • Resistance Level
  • ORIC $14.67
  • THRY $20.66
  • Average True Range (ATR)
  • ORIC 1.56
  • THRY 0.75
  • MACD
  • ORIC -0.45
  • THRY -0.13
  • Stochastic Oscillator
  • ORIC 4.64
  • THRY 28.29

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.

About THRY Thryv Holdings Inc.

Thryv Holdings Inc provides software as service (SaaS) management tools and digital and print marketing tools to small and mid-sized businesses. The company operates in four reportable segments namely Thryv U.S. Marketing Services, Thryv U.S. SaaS, Thryv International Marketing Services, and Thryv International SaaS. It generates maximum revenue from the Thryv U.S. Marketing Services segment.

Share on Social Networks: